Performance of the Oncuria-Detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting
The multiplex Oncuria assay identified bladder cancer with high sensitivity and NPV. Oncuria's high NPV could effectively rule out 66% of patients from requiring subsequent cystoscopy.
Authors
- E. Vian (ORCID: https://orcid.org/0000-0002-5662-7254)
- Zhen Zhang (ORCID: https://orcid.org/0000-0002-4710-9439)
- Charles J. Rosser (ORCID: https://orcid.org/0000-0002-6052-4223)
- Takashi Kobayashi (ORCID: https://orcid.org/0000-0002-9069-5736)
- Kaoru Murakami (ORCID: https://orcid.org/0000-0001-8852-2281)
- Riko Lee
- Ian Pagano (ORCID: https://orcid.org/0000-0002-6248-0113)
- Steve Goodison
- Toru Sakatani (ORCID: https://orcid.org/0009-0004-4994-1503)
- Michael Luu (ORCID: https://orcid.org/0000-0002-7968-7313)
- Hideki Furuya (ORCID: https://orcid.org/0000-0002-9536-8662)
- Sergei Tikhonenkov
- Patrice Hodonou Avogbe (ORCID: https://orcid.org/0000-0003-4436-3981)
- Florence Le Calvez‐Kelm (ORCID: https://orcid.org/0000-0003-0063-5068)
- Howard Kim (ORCID: https://orcid.org/0000-0002-1123-9485)
- Arnaud Manel
Institutions
- University of Hawaiʻi at Mānoa (US)
- Cedars-Sinai Medical Center (US)
- Creusot-Loire Entreprises (France) (FR)
- University of Hawaii System (US)
- Johns Hopkins University (US)
- Kyoto University (JP)
- Cancer Center of Hawaii (US)
- Nonagen Bioscience (United States) (US)
- Mayo Clinic in Florida (US)
- Infirmerie Protestante (FR)
- Centre international de recherche sur le cancer (FR)
- University of Hawaii Cancer Center
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1186/s12967-025-06749-z
- Citations
- 7
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 14.04
Funders
- Division of Cancer Prevention, National Cancer Institute
- Cedars-Sinai Medical Center